The only data Anavex would be collecting is how much blarcamesine is being consumed under the Australian SAS program. Anything else would be anecdotal, which accounts for Missling's vague 10 to 20 patients answer on the call.
Why does Anavex have to be collecting data? If these people are no longer part of a trial, what legal authority does Anavex have to access their health records and collect data?